Health Care & Life Sciences » Pharmaceuticals | Eli Lilly & Co.

Eli Lilly & Co.

Eli Lilly & Co.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 1.07 B
Public Float
 968.44 M
Eli Lilly & Co.
Stock Exchange Mexican Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 1.09 B
Public Float
 968.44 M
Eli Lilly & Co.
Stock Exchange New York Stock Exchange
EPS
 $2.5
Market Cap
 $109.53 B
Shares Outstanding
 970.83 M
Public Float
 916.04 M
Eli Lilly & Co.
Stock Exchange Euronext Paris
EPS
 -
Market Cap
 -
Shares Outstanding
 1.07 B
Public Float
 968.44 M
Eli Lilly & Co.
Stock Exchange SIX Swiss Exchange
EPS
 CHF2.48
Market Cap
 CHF106.79 B
Shares Outstanding
 1.07 B
Public Float
 968.44 M

Profile

Address
Lilly Corporate Center
Indianapolis Indiana 46285
United States
Employees -
Website http://www.lilly.com
Updated 07/08/2019
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through two segments: Human Pharmaceutical Products and Animal Health. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other.

Financials

View All
Created with Highcharts 5.0.14Eli Lilly & Co.Net Income. Fiscal year is January-December. All values USD Millions.4 6854 6852 3912 3912 4082 4082 7382 7382042043 2323 23220132014201520162017201801k2k3k4k5k
Created with Highcharts 5.0.14Eli Lilly & Co.Sales/Revenue. Fiscal year is January-December. All values USD Millions.23 11323 11319 61619 61619 95919 95921 22221 22222 87122 87124 55624 55620132014201520162017201805k10k15k20k25k30k

David A. Ricks
Chairman, President & Chief Executive Officer
Carolyn R. Bertozzi
Independent Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.